000 | 01943 a2200553 4500 | ||
---|---|---|---|
005 | 20250515164717.0 | ||
264 | 0 | _c20090529 | |
008 | 200905s 0 0 eng d | ||
022 | _a1091-6490 | ||
024 | 7 |
_a10.1073/pnas.0900345106 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aReiman, Eric M | |
245 | 0 | 0 |
_aFibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cApr 2009 |
||
300 |
_a6820-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAlzheimer Disease _xgenetics |
650 | 0 | 4 |
_aAmyloid beta-Peptides _xmetabolism |
650 | 0 | 4 |
_aApolipoprotein E4 _xgenetics |
650 | 0 | 4 | _aBrain Mapping |
650 | 0 | 4 | _aCognition |
650 | 0 | 4 | _aGene Dosage |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aHeterozygote |
650 | 0 | 4 | _aHomozygote |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeuropsychological Tests |
700 | 1 | _aChen, Kewei | |
700 | 1 | _aLiu, Xiaofen | |
700 | 1 | _aBandy, Daniel | |
700 | 1 | _aYu, Meixiang | |
700 | 1 | _aLee, Wendy | |
700 | 1 | _aAyutyanont, Napatkamon | |
700 | 1 | _aKeppler, Jennifer | |
700 | 1 | _aReeder, Stephanie A | |
700 | 1 | _aLangbaum, Jessica B S | |
700 | 1 | _aAlexander, Gene E | |
700 | 1 | _aKlunk, William E | |
700 | 1 | _aMathis, Chester A | |
700 | 1 | _aPrice, Julie C | |
700 | 1 | _aAizenstein, Howard J | |
700 | 1 | _aDeKosky, Steven T | |
700 | 1 | _aCaselli, Richard J | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 106 _gno. 16 _gp. 6820-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.0900345106 _zAvailable from publisher's website |
999 |
_c18781685 _d18781685 |